サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/05 | 1,445 | 1,516 | 1,423 | 1,461 | +71 | +5.1% | 1,454,900 |
2021/01/04 | 1,338 | 1,396 | 1,318 | 1,390 | +53 | +4% | 560,000 |
2020/12/30 | 1,346 | 1,346 | 1,314 | 1,337 | -18 | -1.3% | 425,600 |
2020/12/29 | 1,319 | 1,372 | 1,313 | 1,355 | +36 | +2.7% | 396,000 |
2020/12/28 | 1,313 | 1,323 | 1,285 | 1,319 | -4 | -0.3% | 540,100 |
2020/12/25 | 1,326 | 1,352 | 1,318 | 1,323 | -8 | -0.6% | 387,300 |
2020/12/24 | 1,326 | 1,344 | 1,311 | 1,331 | -1 | -0.1% | 453,300 |
2020/12/23 | 1,330 | 1,342 | 1,308 | 1,332 | -4 | -0.3% | 496,100 |
2020/12/22 | 1,363 | 1,384 | 1,335 | 1,336 | -5 | -0.4% | 571,400 |
2020/12/21 | 1,410 | 1,413 | 1,333 | 1,341 | -64 | -4.6% | 910,600 |
2020/12/18 | 1,420 | 1,433 | 1,395 | 1,405 | -19 | -1.3% | 835,800 |
2020/12/17 | 1,525 | 1,588 | 1,395 | 1,424 | +36 | +2.6% | 3,277,300 |
2020/12/16 | 1,388 | 1,388 | 1,388 | 1,388 | -400 | -22.4% | 168,000 |
2020/12/15 | 1,809 | 1,814 | 1,777 | 1,788 | -39 | -2.1% | 406,100 |
2020/12/14 | 1,804 | 1,847 | 1,790 | 1,827 | -53 | -2.8% | 429,000 |
2020/12/11 | 1,890 | 1,909 | 1,863 | 1,880 | +28 | +1.5% | 383,100 |
2020/12/10 | 1,822 | 1,876 | 1,811 | 1,852 | +6 | +0.3% | 454,900 |
2020/12/09 | 1,875 | 1,882 | 1,810 | 1,846 | -46 | -2.4% | 600,200 |
2020/12/08 | 1,981 | 2,031 | 1,861 | 1,892 | -139 | -6.8% | 1,166,400 |
2020/12/07 | 2,093 | 2,106 | 2,010 | 2,031 | -81 | -3.8% | 436,100 |
2020/12/04 | 2,082 | 2,127 | 2,062 | 2,112 | +24 | +1.1% | 357,700 |
2020/12/03 | 2,140 | 2,197 | 2,069 | 2,088 | -33 | -1.6% | 634,000 |
2020/12/02 | 1,955 | 2,126 | 1,950 | 2,121 | +126 | +6.3% | 1,019,200 |
2020/12/01 | 1,979 | 2,032 | 1,930 | 1,995 | +68 | +3.5% | 641,700 |
2020/11/30 | 1,994 | 2,013 | 1,901 | 1,927 | -42 | -2.1% | 628,100 |
2020/11/27 | 1,865 | 1,974 | 1,865 | 1,969 | +105 | +5.6% | 717,300 |
2020/11/26 | 1,832 | 1,884 | 1,805 | 1,864 | +21 | +1.1% | 303,600 |
2020/11/25 | 1,939 | 1,942 | 1,830 | 1,843 | -67 | -3.5% | 734,400 |
2020/11/24 | 1,845 | 1,979 | 1,807 | 1,910 | +182 | +10.5% | 1,756,900 |
2020/11/20 | 1,687 | 1,742 | 1,686 | 1,728 | +27 | +1.6% | 179,900 |
2020/11/19 | 1,710 | 1,713 | 1,681 | 1,701 | -25 | -1.4% | 194,400 |
2020/11/18 | 1,693 | 1,738 | 1,675 | 1,726 | +33 | +1.9% | 221,200 |
2020/11/17 | 1,701 | 1,715 | 1,667 | 1,693 | -15 | -0.9% | 231,300 |
2020/11/16 | 1,735 | 1,743 | 1,702 | 1,708 | -27 | -1.6% | 251,400 |
2020/11/13 | 1,711 | 1,738 | 1,711 | 1,735 | +1 | +0.1% | 182,900 |
2020/11/12 | 1,745 | 1,758 | 1,714 | 1,734 | -15 | -0.9% | 170,900 |
2020/11/11 | 1,741 | 1,782 | 1,735 | 1,749 | -3 | -0.2% | 254,100 |
2020/11/10 | 1,718 | 1,784 | 1,712 | 1,752 | +42 | +2.5% | 354,600 |
2020/11/09 | 1,760 | 1,760 | 1,656 | 1,710 | -56 | -3.2% | 383,000 |
2020/11/06 | 1,722 | 1,775 | 1,702 | 1,766 | +25 | +1.4% | 285,800 |
2020/11/05 | 1,701 | 1,755 | 1,678 | 1,741 | +50 | +3% | 305,900 |
2020/11/04 | 1,698 | 1,713 | 1,666 | 1,691 | +33 | +2% | 251,900 |
2020/11/02 | 1,659 | 1,698 | 1,645 | 1,658 | -3 | -0.2% | 202,000 |
2020/10/30 | 1,744 | 1,744 | 1,645 | 1,661 | -69 | -4% | 292,700 |
2020/10/29 | 1,687 | 1,740 | 1,659 | 1,730 | +3 | +0.2% | 383,400 |
2020/10/28 | 1,751 | 1,782 | 1,715 | 1,727 | -50 | -2.8% | 275,700 |
2020/10/27 | 1,752 | 1,794 | 1,748 | 1,777 | -15 | -0.8% | 240,100 |
2020/10/26 | 1,821 | 1,846 | 1,790 | 1,792 | -5 | -0.3% | 292,200 |
2020/10/23 | 1,756 | 1,818 | 1,731 | 1,797 | +29 | +1.6% | 292,200 |
2020/10/22 | 1,821 | 1,838 | 1,757 | 1,768 | -62 | -3.4% | 412,200 |
1101~
1150
件表示中 / 2502件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 213,400円 | - | - | 0.00% | - | 98.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 380,300円 | -6.4% | -71.8% | 5.00% | 42.48倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 313,000円 | +21.7% | +999.9% | 0.00% | 13.11倍 | 4.34倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
東和薬品 | 292,800円 | +7.9% | -3.3% | 2.73% | 8.14倍 | 0.84倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 204,600円 | +3.1% | -6.5% | 2.35% | 9.49倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム